Cleared Traditional

K254265 - Helion Viewer Suite

K254265 is an FDA 510(k) clearance for Helion Viewer Suite, manufactured by Videomed Srl ( a Baxter Healthcare Corp company). The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 148-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2026
Decision
148d
Days
Class 2
Risk

K254265 is an FDA 510(k) clearance for the Helion Viewer Suite. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Videomed Srl ( a Baxter Healthcare Corp company) (Limena (Pd), IT). The FDA issued a Cleared decision on May 27, 2026 after a review of 148 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Videomed Srl ( a Baxter Healthcare Corp company) devices

FDA 510(k) Submission Details - K254265

510(k) Number K254265 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 30, 2025
Decision Date May 27, 2026
Days to Decision 148 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 107d · This submission: 148d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1761
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K254265.
Perfusion Measurement Platform v1
K253421 · Quantified Imaging Limited · Jun 2026
2D Hip Planning Software
K261352 · One Ortho · Jun 2026
CustoMED Viewer
K260116 · CustoMED , Ltd. · Jun 2026
CMN Capillary Function with Virtual Expert for MRI, CT and CBCT
K253831 · Cercare Medical A/S · May 2026
SubtleHD-PET (1.x)
K254013 · Subtle Medical, Inc. · May 2026
HipGuide (V 1.0.0.0)
K260321 · Orthopedic Driven Imaging, LLC · May 2026